Supremex Announces Results for the First Quarter of 2025 and its Intention to Renew Normal Course Issuer Bid ("NCIB")

Stock Information for Medexus Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Medexus Pharmaceuticals Inc.

Supremex Reports Voting Results from its Annual General Meeting
REPEAT - Supremex Announces Date of Its 2025 First Quarter Results Conference Call and Annual Meeting of Shareholders
Supremex Announces Date of Its 2025 First Quarter Results Conference Call and Annual Meeting of Shareholders
Supremex Announces Departure of Chief Financial Officer
Supremex Announces Q4 and Year-End 2024 Results
REMINDER: Supremex Announces Date of Its 2024 Fourth Quarter Results Conference Call
Supremex Announces Date of Its 2024 Fourth Quarter Results Conference Call
Supremex Announces Results for the Third Quarter of 2024 and Intention to Proceed With a Sale & Leaseback of Two Properties in Addition to Increase Quarterly Dividend by 25%

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.